Cisapride monohydrate

• CAT Number: I024804
• CAS Number: 260779-88-2
• Molecular Formula: C23H31ClFN3O5
• Molecular Weight: 483.96
• Purity: ≥95%
• Solubility: Soluble in DMSO
• Storage: Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
• IUPAC Name: 4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide;hydrate
• InChI: InChI=1S/C23H29ClFN3O4.H2O/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16;/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29);1H2/t20-,22+;/m0./s1
• InChIKey: QBYYXIDJOFZORM-IKGOIYPNSA-N
• SMILES: CO[C@@H]1CN(CC[C@@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F.O

Cisapride monohydrate (Cat.No:I024804) is a gastroprokinetic agent, a drug that increases motility in the upper gastrointestinal tract. It acts directly as a serotonin 5-HT₄ receptor agonist and indirectly as a parasympathomimetic. Stimulation of the serotonin receptors increases acetylcholine release in the enteric nervous system.

Reference

1: Zhou X, Zhang Q, Zhao T, Bai X, Yuan W, Wu Y, Liu D, Li S, Ju J, Chege Gitau S, Chu W, Xu C, Lu Y. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3. Eur J Pharmacol. 2014 Jul 15;735:202-10. doi: 10.1016/j.ejphar.2014.04.012. Epub 2014 Apr 21. PubMed PMID: 24769415.
2: Durdagi S, Randall T, Duff HJ, Chamberlin A, Noskov SY. Rehabilitating drug-induced long-QT promoters: in-silico design of hERG-neutral cisapride analogues with retained pharmacological activity. BMC Pharmacol Toxicol. 2014 Mar 8;15:14. doi: 10.1186/2050-6511-15-14. PubMed PMID: 24606761; PubMed Central PMCID: PMC4016140.
3: Mt-Isa S, Tomlin S, Sutcliffe A, Underwood M, Williamson P, Croft NM, Ashby D. Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide. J Pediatr Gastroenterol Nutr. 2015 Apr;60(4):508-14. doi: 10.1097/MPG.0000000000000657. PubMed PMID: 25825854.
4: Kempf J, Lewis F, Reusch CE, Kook PH. High-resolution manometric evaluation of the effects of cisapride and metoclopramide hydrochloride administered orally on lower esophageal sphincter pressure in awake dogs. Am J Vet Res. 2014 Apr;75(4):361-6. doi: 10.2460/ajvr.75.4.361. PubMed PMID: 24669921.
5: Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL. Cisapride for intestinal constipation. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD007780. doi: 10.1002/14651858.CD007780.pub2. Review. PubMed PMID: 21249695.
6: Quigley EM. Cisapride: what can we learn from the rise and fall of a prokinetic? J Dig Dis. 2011 Jun;12(3):147-56. doi: 10.1111/j.1751-2980.2011.00491.x. Review. PubMed PMID: 21615867.
7: Ullal TV, Kass PH, Conklin JL, Belafsky PC, Marks SL. High-resolution manometric evaluation of the effects of cisapride on the esophagus during administration of solid and liquid boluses in awake healthy dogs. Am J Vet Res. 2016 Aug;77(8):818-27. doi: 10.2460/ajvr.77.8.818. PubMed PMID: 27463544.
8: Al Okab RA. Cisapride a green analytical reagent for rapid and sensitive determination of bromate in drinking water, bread and flour additives by oxidative coupling spectrophotometric methods. Spectrochim Acta A Mol Biomol Spectrosc. 2013 Feb 15;103:333-7. doi: 10.1016/j.saa.2012.10.071. Epub 2012 Nov 23. PubMed PMID: 23261631.
9: Cameron JC, Vaillancourt R, Major-Cook N, Boland M, Zucker M, Lariviere D. Clinical recovery of chronic intestinal pseudo-obstruction with cisapride in a complex pediatric patient. Am J Hosp Palliat Care. 2013 Jun;30(4):403-5. doi: 10.1177/1049909112457238. Epub 2012 Sep 9. PubMed PMID: 22964344.
10: Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet. 2000 Jul;39(1):49-75. Review. PubMed PMID: 10926350.
11: Maclennan S, Augood C, Cash-Gibson L, Logan S, Gilbert RE. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev. 2010 Apr 14;(4):CD002300. doi: 10.1002/14651858.CD002300.pub2. Review. PubMed PMID: 20393933.
12: Louis H. [Management of gastroparesis and functional dyspepsia after cisapride withdrawal]. Rev Med Brux. 2012 Sep;33(4):425-9. Review. French. PubMed PMID: 23091951.
13: Kirch W, Janisch HD, Ohnhaus EE, van Peer A. Cisapride-cimetidine interaction: enhanced cisapride bioavailability and accelerated cimetidine absorption. Ther Drug Monit. 1989;11(4):411-4. PubMed PMID: 2741189.
14: Gales MA, Harms DW. Is rectally administered cisapride an effective prokinetic agent? Ann Pharmacother. 1999 Nov;33(11):1217-20. Review. PubMed PMID: 10573323.
15: van Haarst AD, van ‘t Klooster GA, van Gerven JM, Schoemaker RC, van Oene JC, Burggraaf J, Coene MC, Cohen AF. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clin Pharmacol Ther. 1998 Nov;64(5):542-6. PubMed PMID: 9834046.
16: Hegar B, Alatas S, Advani N, Firmansyah A, Vandenplas Y. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study. Acta Paediatr. 2009 Apr;98(4):750-5. doi: 10.1111/j.1651-2227.2008.01158.x. Epub 2008 Dec 10. PubMed PMID: 19076984.
17: Offman EM, Freeman DJ, Dresser GK, Munoz C, Bend JR, Bailey DG. Red wine-cisapride interaction: comparison with grapefruit juice. Clin Pharmacol Ther. 2001 Jul;70(1):17-23. PubMed PMID: 11452240.
18: Lowry JA, Kearns GL, Abdel-Rahman SM, Nafziger AN, Khan IS, Kashuba AD, Schuetz EG, Bertino JS Jr, van den Anker JN, Leeder JS. Cisapride: a potential model substrate to assess cytochrome P4503A4 activity in vivo. Clin Pharmacol Ther. 2003 Mar;73(3):209-22. PubMed PMID: 12621386.
19: Ward RM, Lemons JA, Molteni RA. Cisapride: a survey of the frequency of use and adverse events in premature newborns. Pediatrics. 1999 Feb;103(2):469-72. PubMed PMID: 9925843.
20: Premji SS, Paes B. Cisapride: the problem of the heart. Neonatal Netw. 1999 Oct;18(7):21-5. Review. PubMed PMID: 10808885.